Pathogenicity scoring system for human clinical genetics

Provided are methods and systems for determining the clinical significance of a genetic variant. The methods entail determining, for the variant, (a) a function score based on known impact of the variant on a biological function of a cell or protein, (b) a frequency score based on the frequency of t...

Full description

Saved in:
Bibliographic Details
Main Authors Divincenzo, Christina, McCarthy, Michele, Jones, Jeffery, Elzinga, Christopher, Medeiros, Katelyn, Maston, Glenn, Braastad, Corey, Karbassi, Izabela, Batish, Sat Dev, Higgins, Joseph, Lapierre, Jennifer, Dubois, Felicita
Format Patent
LanguageEnglish
Published 01.09.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Provided are methods and systems for determining the clinical significance of a genetic variant. The methods entail determining, for the variant, (a) a function score based on known impact of the variant on a biological function of a cell or protein, (b) a frequency score based on the frequency of the variant in a population, (c) a co-occurrence score based on how the variant co-occurs with a reference variant having known clinical significance relating to a clinical disease or condition, and (d) a family segregation score based on how the variant segregates with a disease or condition in a family; and aggregating, on a computer, the function score, the frequency score, the co-occurrence score, the family segregation score to generate a clinical significance score indicating the clinical significance of the genetic variant.
Bibliography:Application Number: US201415028190